News | March 12, 2015

Novel Thrombectomy Device Removes Large Blood Clots From Patient's Veins

Aspire system used to treat occluded inferior vena cave, deep vein thrombosis

Aspire, Pablo Uceda, DFW Vascular, deep vein thrombosis, thrombectomy

March 12, 2015 — Pablo Uceda, M.D., vascular surgeon with DFW Vascular, Dallas, Texas, was successful in using a new device to clear blood clots out of a patient's legs.

The patient presented with an occluded inferior vena cava and a deep vein thrombosis. The blood clots caused swelling and pain in the legs and potentially could migrate to other areas of the body including the lungs, which can be life-threatening. Removing all of the blood clots quickly is important.

Uceda first infused tissue plasminogen activator (tPA), a thrombolytic agent, into the veins then performed angioplasty. Once angioplasty was performed the clots in the veins were broken up and needed to be removed. Uceda then used the Aspire Mechanical Thrombectomy system to remove the blood clots.

"Removing large blood clots is not easy to do. Many available devices are not able to remove the entire clot, leaving residual clot behind," said Uceda. "The Aspire Mechanical Thrombectomy device has a high aspiration force; this allowed me to remove the entire clot."

The Aspire Mechanical Thrombectomy System allows clinicians to instantly start, stop, increase, decrease, pulse or maintain thrombectomy force during a procedure. Aspire Mechanical Aspirators also aspirate up to 280ml, almost 10 times more than basic syringe-based systems, without multiple messy and time-consuming catheter connections, disconnections, and re-connections to improve speed and performance.

The Aspire Mechanical Thrombectomy System is available by itself or in kits that include an over-the-wire or rapid exchange thrombectomy catheter. Aspire Mechanical Aspirators may also be connected to any thrombectomy catheter the clinician chooses. 

For more information:

Related Content

ACCESS PTS Study Demonstrates Efficacy of EKOS Therapy for Post-Thrombotic Syndrome
News | Deep Vein Thrombosis| July 07, 2017
BTG plc recently highlighted the results of the ACCESS PTS trial, presented at the Society for Vascular Medicine 28th...
Sponsored Content | Videos | Venous Therapies| June 27, 2017
This video, provided by Ekos, demonstrates the EkoSonic endovascular System thrombolytic system to treat deep vein th
New Data Demonstrate Clinical and Quality-of-Life Benefits for VenaSeal Closure System in Venous Reflux Disease Patients
News | Venous Therapies| May 05, 2017
Medtronic plc recently announced three-year outcomes from the VeClose U.S. pivotal clinical trial and one-year data...
News | Venous Therapies| April 26, 2017
A new Varicose Vein Registry has begun producing useful outcomes information, as reported in the May edition of the...
Technology | Pulmonary Embolism| March 01, 2017
March 1, 2017 — BTG plc announced U.S.
global thrombectomy devices market, Allied Market Research report, 2022
News | Thrombectomy Devices| January 05, 2017
January 5, 2017 — A new report published by Allied Market Research forecasts that the global...
News | Analytics Software| October 31, 2016
In an effort to improve patient care, Children's Hospital of Philadelphia's (CHOP) Information Services team is using...
Neuravi, EmboTrap II stent retriever, thrombectomy device, acute stroke, European launch, CE Mark
News | Thrombectomy Devices| September 28, 2016
Neuravi recently announced Conformité Européenne (CE) Mark approval and launch of the company’s newly available...
News | Venous Therapies| September 12, 2016
Veniti Inc. has closed on $25 million in Series D equity financing from Boston Scientific Corp. The funds will allow...
Overlay Init